Regeneron is to pay $256 million in cash to acquire “substantially all” of 23andMe’s assets, including its massive biobank of around 15 million customer genetic samples and data.
Regeneron is to pay $256 million in cash to acquire “substantially all” of 23andMe’s assets, including its massive biobank of around 15 million customer genetic samples and data.
Doubtful. Even one of me is pretty lazy. They’ll want someone more apt for their clone army.
Don’t worry that’s the parts they will genetically modify to make you more docile and servile.